95377-96-1 Usage
Uses
Used in Drug Discovery and Medicinal Chemistry:
1-Methyl-6,8,9-trimethoxy-1H-[1]benzoxepino[2,3,4-ij]isoquinoline-2,3-dione is used as a potential candidate in drug discovery and medicinal chemistry due to its structural complexity and pharmacological properties. Its unique molecular structure allows for exploration in the development of new therapeutic agents.
Used in Research into Natural Product Synthesis:
1-Methyl-6,8,9-trimethoxy-1H-[1]benzoxepino[2,3,4-ij]isoquinoline-2,3-dione is used as a subject of research in the field of natural product synthesis. Its complex structure provides opportunities for the development of novel synthetic pathways and methods, potentially leading to the creation of new bioactive compounds.
Used in Chemical Biology:
1-Methyl-6,8,9-trimethoxy-1H-[1]benzoxepino[2,3,4-ij]isoquinoline-2,3-dione is used in chemical biology for studying its interactions with biological systems. Its unique molecular structure may offer insights into the mechanisms of action and potential applications in modulating biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 95377-96-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,3,7 and 7 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 95377-96:
(7*9)+(6*5)+(5*3)+(4*7)+(3*7)+(2*9)+(1*6)=181
181 % 10 = 1
So 95377-96-1 is a valid CAS Registry Number.
95377-96-1Relevant academic research and scientific papers
Campello, M. J.,Castedo, L.,Dominguez, D.,Lera, A. Rodriguez de,Saa, J. M.,et al.
, p. 5933 - 5936 (1984)
Structure 1a, 3, and 6 were deduced for the new oxoisocularine alkaloids, oxosarcophylline, yagonine and aristoyagonine, respectively, on the basis of spectroscopic studies and synthesis.
Synthetic Approaches To Cularines. II . Ullmann Condensation.
Lera, Angel Rodrigues de,Suau, Rafael,Castedo, Luis
, p. 313 - 319 (2007/10/02)
The first total syntheses of O-methylcularicine 9b and sarcocapnine 9c are described together with a new synthesis of cularine 9a using the Ullmann condensation reaction of the appropriate 2'-bromo-8-hydroxytetrahydrobenzylisoquinoline formed by phase-tra
